Pulmonary Disease, Chronic Obstructive Clinical Trial
Official title:
Specialized Center of Clinically Oriented Research: Alveolar and Airway Mechanisms for COPD. Detection: Lung Imaging and Profiling (Project 1)
Chronic obstructive pulmonary disease (COPD) is a long-term lung disease. People with COPD have difficulty breathing because of lung damage. However, for many people with COPD, while some areas of the lungs are damaged, other nearby areas are not. This study will examine lung tissue from people with and without COPD who are undergoing lung transplantation to investigate how and why certain areas of the lungs are damaged in some people but not others.
COPD is a common lung disease and is the fourth most common cause of death in the United
States. Symptoms include coughing, excess mucus production, shortness of breath,and wheezing.
There is no cure for COPD, and the disease worsens over time. Treatment can include stopping
smoking, taking medications, receiving supplemental oxygen, and in severe cases, undergoing
lung transplantation. COPD is usually the result of many years of cigarette smoking, but it
remains unknown exactly how cigarette smoking causes this disease.
One reason that people with COPD experience shortness of breath and cough is because the lung
airways are partly damaged and obstructed. In healthy people, oxygen is breathed in and then
passes easily into the bloodstream through bunches of small air sacs that fill the lungs. In
people with COPD, these air sacs are damaged, making it difficult for oxygen to pass into the
bloodstream. However, even in people with severe COPD, the air sacs in some areas of the
lungs continue to work, even though neighboring air sacs are damaged. It is possible that an
overactive immune response may cause the air sac damage and that some people with COPD are
more prone than others to such immune system abnormalities. By examining the differences in
lung tissue in people with and without COPD who are undergoing a lung transplant, this study
will investigate why some people's immune systems cause lung damage and others do not and how
and why some air sacs are damaged while other nearby air sacs are not. Study researchers will
also examine whether genetic factors play a role in the development and severity of COPD.
This study will enroll people with COPD who are undergoing lung transplantation. Before the
lung transplantation surgery, participants will attend one study visit, which will include a
medical history review, height and weight measurements, and a blood collection. A portion of
blood will be stored for future genetic research. Participants will also complete
questionnaires to collect information on activities, health, and quality of life. Some
participants will undergo a 3-Helium magnetic resonance imaging (MRI) procedure, which is an
imaging technique that allows doctors to see the air spaces inside of the lungs. After the
lung transplantation surgery, study researchers will collect lung tissue from surgery. Study
researchers will contact participants at the end of the study to collect follow-up medical
information.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|